PDGFRα/FLT3-ITD-IN-3 (Compound 18d) 是一种有效的PDGFRα/FLT3抑制剂，IC50s 分别为 0.153 和 0.004 μM。PDGFRα/FLT3-ITD-IN-3 具有研究急性髓系白血病或慢性嗜酸性粒细胞白血病的潜力。

PDGFRα/FLT3-ITD-IN-3 (Compound 18d) is a potent inhibitor of PDGFRα / FLT3 with IC 50 s of 0.153 and 0.004 μM, respectively. PDGFRα/FLT3-ITD-IN-3 has the potential for the research of acute myeloid leukemia or chronic eosinophilic leukemia [1].

2761259-22-5

C26H39N9

477.65

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years